Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,176.00
(
-0.11%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.20
(
4.63%
)
Bitcoin
78,244.28
(
0.01%
)
News Focus
News Focus
Post# of 27661
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bow-tie

Send PM Follow Ignore
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

bow-tie

Re: Work Harder post# 23498

Sunday, 03/07/2021 11:28:07 AM

Sunday, March 07, 2021 11:28:07 AM

Post# of 27661
Nice!! ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
STATUS
Not Recruiting
PARTICIPANTS NEEDED
400
SPONSOR
Anergis
Updated on 22 January 2021

https://www.centerwatch.com/clinical-trials/listings/104518/allergic-rhinitis-atibar--efficacy-safety/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote